Advanced search
Publication Cover
Ophthalmic Epidemiology Volume 19, 2012 - Issue 2
Submit an article Journal homepage
1,295
Views
27
CrossRef citations to date
0
Altmetric
Original Article

Managing Glaucoma in those with Co-morbidity: Not as Easy as it Seems

Elizabeth E. RougheadSansom Institute, School of Pharmacy and Medical Sciences, University of South Australia, Adelaide, Australia
,
Lisa M. KalischSansom Institute, School of Pharmacy and Medical Sciences, University of South Australia, Adelaide, AustraliaCorrespondence[email protected]
,
Nicole L. PrattSansom Institute, School of Pharmacy and Medical Sciences, University of South Australia, Adelaide, Australia
,
Graeme KillerDepartment of Veterans’ Affairs, Canberra, Australia
,
Amanda BarnardSchool of General Practice, Rural and Indigenous Health, Medical School, Australian National University, Canberra, Australia
&
Andrew L. GilbertSansom Institute, School of Pharmacy and Medical Sciences, University of South Australia, Adelaide, Australia
Pages 74-82 | Received 30 Nov 2010, Accepted 23 Aug 2011, Published online: 24 Feb 2012

Citations (27)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Sky K Chew, Simon E Skalicky & Ivan Goldberg. (2014) Brinzolamide plus brimonidine for the treatment of glaucoma: an update. Expert Opinion on Pharmacotherapy 15:16, pages 2461-2471.
Read now
Jess T Whitson, Tony Realini, Quang H Nguyen, Matthew G McMenemy & Stephen M Goode. (2013) Six-month results from a Phase III randomized trial of fixed-combination brinzolamide 1% + brimonidine 0.2% versus brinzolamide or brimonidine monotherapy in glaucoma or ocular hypertension. Clinical Ophthalmology 7, pages 1053-1060.
Read now

Articles from other publishers (25)

Oriane Adrien, Atiya K. Mohammad, Jacqueline G. Hugtenburg, Lisa M. McCarthy, Simone Priester-Vink, Robbert Visscher, Patricia M. L. A. van den Bemt, Petra Denig & Fatma Karapinar-Carkıt. (2023) Prescribing Cascades with Recommendations to Prevent or Reverse Them: A Systematic Review. Drugs & Aging 40:12, pages 1085-1100.
Crossref
Michael Lee Groff, Bohmyi Choi, Tony Lin, Ian Mcllraith, Cindy Hutnik & Monali S. Malvankar-Mehta. (2023) Anxiety, depression, and sleep-related outcomes of glaucoma patients: systematic review and meta-analysis. Canadian Journal of Ophthalmology 58:4, pages 346-355.
Crossref
Junran Sun, Tong Li, Xiaohuan Zhao, Bing Lu, Jieqiong Chen, Wenjia Liu, Minwen Zhou & Xiaodong Sun. (2022) Prevalence and Risk Factors of Glaucoma Among Chinese People From the China Health and Retirement Longitudinal Study. Journal of Glaucoma 31:10, pages 789-795.
Crossref
Ann S. Doherty, Faiza Shahid, Frank Moriarty, Fiona Boland, Barbara Clyne, Tobias Dreischulte, Tom Fahey, Seán P. Kennelly & Emma Wallace. (2022) Prescribing cascades in community‐dwelling adults: A systematic review. Pharmacology Research & Perspectives 10:5.
Crossref
N. A. Bakunina & L. N. Kolesnikova. (2022) The life style of glaucoma patients: a scientific rationale for basic recommendations. Russian Ophthalmological Journal 15:3, pages 150-156.
Crossref
Earl J. Morris, Josef Hollmann, Ann-Kathrin Hofer, Hemita Bhagwandass, Razanne Oueini, Lauren E. Adkins, Jesper Hallas & Scott M. Vouri. (2022) Evaluating the use of prescription sequence symmetry analysis as a pharmacovigilance tool: A scoping review. Research in Social and Administrative Pharmacy 18:7, pages 3079-3093.
Crossref
I. S. Makogon, D. I. Ivanova & A. L. Onishchenko. (2022) Beta-blockers: issues of drug interactions in local and systemic delivery. National Journal glaucoma 21:2, pages 84-92.
Crossref
Govindasamy Kumaramanickavel, Siddhita Jadhav, Sugirdhana Parthiban Ramsait & Pinakin Gunvant Davey. 2022. Glaucoma - Recent Advances and New Perspectives [Working Title]. Glaucoma - Recent Advances and New Perspectives [Working Title].
Ai Kido, Masahiro Miyake, Tadamichi Akagi, Hanako Ohashi Ikeda, Takanori Kameda, Kenji Suda, Tomoko Hasegawa, Shusuke Hiragi, Satomi Yoshida, Akitaka Tsujikawa, Hiroshi Tamura & Koji Kawakami. (2021) Association between topical β-blocker use and asthma attacks in glaucoma patients with asthma: a cohort study using a claims database. Graefe's Archive for Clinical and Experimental Ophthalmology 260:1, pages 271-280.
Crossref
A. V. Kuroyedov, A. B. Movsisyan, E.  A. Egorov,  V. P. Erichev,  V.  V. Gorodnichy, A. Yu. Brezhnev & I. R. Gazizova. (2021) The profile of patients with primary open-angle glaucoma in the Russian Federation (preliminary results of a multicenter population-based study). Part 2. National Journal glaucoma 20:2, pages 31-42.
Crossref
L. V. Yakubova, S. M. Kosakyan & L. V. Vasilenkova. (2020) Sustainable treatment of glaucoma patients with cardiovascular diseases. Russian Ophthalmological Journal 13:3, pages 103-107.
Crossref
Tesfahun C. Eshetie, Tuan A. Nguyen, Marianne H. Gillam & Lisa M. Kalisch Ellett. (2019) Potentially inappropriate prescribing in people with dementia: An Australian population‐based study. International Journal of Geriatric Psychiatry 34:10, pages 1498-1505.
Crossref
Gus Gazzard, Evgenia Konstantakopoulou, David Garway-Heath, Anurag Garg, Victoria Vickerstaff, Rachael Hunter, Gareth Ambler, Catey Bunce, Richard Wormald, Neil Nathwani, Keith Barton, Gary Rubin, Stephen Morris & Marta Buszewicz. (2019) Selective laser trabeculoplasty versus drops for newly diagnosed ocular hypertension and glaucoma: the LiGHT RCT. Health Technology Assessment 23:31, pages 1-102.
Crossref
V Srinithi & R Lavanya. (2019) Novel Colour Derivative Based Approach for CDR Estimation in Glaucoma Diagnosis. Novel Colour Derivative Based Approach for CDR Estimation in Glaucoma Diagnosis.
V. P. Erichev & A. S. Makarova. (2019) Сompatibility of Systemic Drugs and Local Antihypertensive Therapy in Patients with Primary Open-Angle Glaucoma (Analytical Review). Ophthalmology in Russia 15:4, pages 366-373.
Crossref
Demy L. Idema, Yuanyuan Wang, Michael Biehl, Peter L. Horvatovich & Eelko Hak. (2018) Effect estimate comparison between the prescription sequence symmetry analysis (PSSA) and parallel group study designs: A systematic review. PLOS ONE 13:12, pages e0208389.
Crossref
Nicole Pratt & Elizabeth Roughead. (2018) Assessment of Medication Safety Using Only Dispensing Data. Current Epidemiology Reports 5:4, pages 357-369.
Crossref
Tsontcho Ianchulev, Arturo Chayet, Malik Kahook, Mark Packer, Louis Pasquale & Robert N Weinreb. (2016) Pharmacodynamic profile of mydriatic agents delivered by ocular piezo-ejection microdosing compared with conventional eyedropper. Therapeutic Delivery 7:11, pages 751-760.
Crossref
Ah Reum Jeong, Chan Yun Kim, Min Hee Kang & Na Rae Kim. (2016) Psychological Aspects of Glaucoma. Journal of Nervous & Mental Disease 204:3, pages 217-220.
Crossref
Fulya Duman, Michael Waisbourd, Bruno Faria, Victoria Addis, Michael Hsieh, Feyzahan Ekici, Lisa A. Hark & George L. Spaeth. (2016) Trabeculectomy in Patients With Glaucoma Over 80 Years of Age. Journal of Glaucoma 25:3, pages e123-e127.
Crossref
Sallie-Anne Pearson, Nicole Pesa, Julia M. Langton, Annabelle Drew, Margaret Faedo & Jane Robertson. (2015) Studies using Australia's Pharmaceutical Benefits Scheme data for pharmacoepidemiological research: a systematic review of the published literature (1987-2013). Pharmacoepidemiology and Drug Safety 24:5, pages 447-455.
Crossref
Sarah L. Greig & Emma D. Deeks. (2015) Brinzolamide/Brimonidine: A Review of Its Use in Patients with Open-Angle Glaucoma or Ocular Hypertension. Drugs & Aging 32:3, pages 251-260.
Crossref
Nicole L. Pratt, Emmae N. Ramsay, Lisa M. Kalisch Ellett, Tuan A. Nguyen & Elizabeth E. Roughead. (2015) Association between Ophthalmic Timolol and Hospitalisation for Bradycardia. Journal of Ophthalmology 2015, pages 1-6.
Crossref
Rohan A. Elliott & Jane C. Booth. (2014) Problems with medicine use in older Australians: a review of recent literature. Journal of Pharmacy Practice and Research 44:4, pages 258-271.
Crossref
T Realini, Q H Nguyen, G Katz & H DuBiner. (2013) Fixed-combination brinzolamide 1%/brimonidine 0.2% vs monotherapy with brinzolamide or brimonidine in patients with open-angle glaucoma or ocular hypertension: results of a pooled analysis of two phase 3 studies. Eye 27:7, pages 841-847.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.